
Currently out of the existing stock ratings of Jack Allen, 12 are a HOLD (16%), 63 are a BUY (84%).
Analyst Jack Allen, currently employed at BAIRD, has had 35.09% of price targets met with an average potential upside of 44.04%, reached in 77 days on average.
Jack Allen has documented 140 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CLLS, at 15-Sep-2026.
Analyst best performing recommendations are on RCOR (RENOVACOR).
The best stock recommendation documented was for ACLX (ARCELLX) on 4/13/2023. The price target of $39 was fulfilled within 8 days with a profit of $9.7 (33.11%), with a performance score of 41.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Aug-2026
$6
$4.96 (476.92%)
$5
3 months 2 days ago
(17-Aug-2026)
1/10 (10%)
$3.92 (188.46%)
148
Buy Since 15-Apr-2026
$10
$8.5 (566.67%)
$10
6 months 28 days ago
(22-Apr-2026)
0/2 (0%)
$7.61 (318.41%)
Sell Since 16-Apr-2026
7 months 3 days ago
(16-Apr-2026)
0/3 (0%)
$2.86 (55.64%)
Buy Since 04-Apr-2023
$11
$9.96 (957.69%)
$12
7 months 3 days ago
(16-Apr-2026)
0/12 (0%)
$8.63 (364.14%)
Hold Since 21-Mar-2023
$3.85
$2.81 (270.19%)
$6
7 months 5 days ago
(14-Apr-2026)
1/2 (50%)
$1.57 (68.86%)
44
Which stock is Jack Allen most bullish on?
Which stock is Jack Allen most reserved on?
What Year was the first public recommendation made by Jack Allen?